News|Articles|August 1, 2025
How One Neuro Brand Cut Through Prior Auth Barriers
Case study on how a neuro biologic brand leveraged SamaCare’s insights and interventions platform to decrease patient access friction and improve patient starts.
Trending on PharmExec
1
FDA Pannel Votes to Loosen Restrictions for Four Peptides
2
Pharmaceutical Executive Daily: FDA Votes to Reduce Restrictions on Four Peptides
3
President Trump Announces Phased Generic Drug Tariff Plan: Report
4
Retatrutide Delivers Up to 22.6% Weight Loss in Two New Phase III Trials
5